Xu Zhang

9.8k total citations · 2 hit papers
324 papers, 6.4k citations indexed

About

Xu Zhang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xu Zhang has authored 324 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Surgery, 107 papers in Pulmonary and Respiratory Medicine and 102 papers in Molecular Biology. Recurrent topics in Xu Zhang's work include Renal cell carcinoma treatment (56 papers), Cancer-related molecular mechanisms research (34 papers) and Bladder and Urothelial Cancer Treatments (32 papers). Xu Zhang is often cited by papers focused on Renal cell carcinoma treatment (56 papers), Cancer-related molecular mechanisms research (34 papers) and Bladder and Urothelial Cancer Treatments (32 papers). Xu Zhang collaborates with scholars based in China, United States and Philippines. Xu Zhang's co-authors include Zhijian J. Chen, Lijun Sun, Jiaxi Wu, Xuewu Zhang, Zhu‐Hong You, Chenggang Yan, Xing Chen, Chuo Chen, Heping Shi and Xin Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Xu Zhang

289 papers receiving 6.3k citations

Hit Papers

Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages I... 2013 2026 2017 2021 2013 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Zhang China 36 2.7k 1.5k 1.4k 1.4k 1.1k 324 6.4k
Iris Barshack Israel 46 3.3k 1.2× 1.3k 0.8× 1.6k 1.1× 1.8k 1.2× 798 0.7× 258 8.1k
Hyung J. Chun United States 32 1.8k 0.7× 974 0.6× 724 0.5× 1.1k 0.8× 581 0.5× 65 4.5k
Wolfram Ruf United States 70 4.0k 1.4× 2.4k 1.6× 2.2k 1.5× 1.0k 0.7× 1.5k 1.3× 280 15.7k
Éric Boilard Canada 45 3.5k 1.3× 1.7k 1.1× 1.1k 0.8× 537 0.4× 501 0.4× 125 7.1k
Matthias Clauss United States 43 4.8k 1.8× 2.4k 1.6× 1.5k 1.0× 971 0.7× 751 0.7× 107 9.3k
Xiang Cheng China 46 2.5k 0.9× 2.1k 1.4× 1.0k 0.7× 838 0.6× 623 0.6× 226 6.6k
Stéphane Heymans Netherlands 63 5.7k 2.1× 1.1k 0.7× 3.4k 2.4× 2.0k 1.4× 1.0k 0.9× 253 14.6k
Mortimer Poncz United States 65 3.5k 1.3× 2.1k 1.4× 625 0.4× 3.5k 2.4× 1.0k 0.9× 287 13.3k
Naoyuki Kamatani Japan 51 2.8k 1.0× 1.3k 0.9× 1.3k 0.9× 905 0.6× 799 0.7× 179 8.9k
Steven J. Harper United Kingdom 51 4.6k 1.7× 810 0.5× 1.0k 0.7× 625 0.4× 753 0.7× 143 8.3k

Countries citing papers authored by Xu Zhang

Since Specialization
Citations

This map shows the geographic impact of Xu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Zhang more than expected).

Fields of papers citing papers by Xu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Zhang. The network helps show where Xu Zhang may publish in the future.

Co-authorship network of co-authors of Xu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Zhang. A scholar is included among the top collaborators of Xu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Zhang. Xu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xing, Shaoqing Yu, Wenjie Wei, et al.. (2025). Fe‐S Protein FDX1 Triggers Tumor‐Intrinsic Innate Immunity via Mitochondrial Nucleic Acids Release to Orchestrate Ferroptosis in CCRCC. Advanced Science. 13(6). e18323–e18323.
2.
Xia, Baijin, Xinmiao Jiang, Jialing Guo, et al.. (2025). Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy. Pharmacological Research. 213. 107628–107628. 4 indexed citations
3.
Wang, Huan, Bingnan Gu, Zixuan Wang, et al.. (2025). Emodin enhances host antiviral immunity against Micropterus salmoides rhabdovirus by activating RLR signaling in largemouth bass. Fish & Shellfish Immunology. 166. 110633–110633.
4.
Huang, Xing, Shuo Tian, Jichen Wang, et al.. (2024). Upregulation of serine metabolism enzyme PSAT1 predicts poor prognosis and promotes proliferation, metastasis and drug resistance of clear cell renal cell carcinoma. Experimental Cell Research. 437(1). 113977–113977. 6 indexed citations
5.
Zhang, Xu, Tak‐Wah Lam, & Hing‐Fung Ting. (2023). Genome instability-derived genes as a novel prognostic signature for lung adenocarcinoma. Frontiers in Cell and Developmental Biology. 11. 1224069–1224069. 2 indexed citations
6.
Xu, Wenping, Xu Zhang, Dan‐Yang Wang, et al.. (2023). BM-MSCs overexpressing the Numb enhance the therapeutic effect on cholestatic liver fibrosis by inhibiting the ductular reaction. Stem Cell Research & Therapy. 14(1). 45–45. 9 indexed citations
8.
Zhu, Meng, Zhimin Ma, Xu Zhang, et al.. (2022). C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis. BMC Medicine. 20(1). 301–301. 93 indexed citations
9.
Peng, Cheng, Qingbo Huang, Shichao Li, et al.. (2022). Effects of Retroperitoneal or Transperitoneal Pneumoperitoneum on Inferior Vena Cava Hemodynamics and Cardiopulmonary Function: A Prospective Real-Time Comparison. Journal of Endourology. 37(1). 28–34. 2 indexed citations
11.
Gao, Yu, Hongzhao Li, Yuanxin Yao, et al.. (2020). Vessel and Tension-Free Reconstruction During Robot-Assisted Partial Nephrectomy for Hilar Tumors: “Garland” Technique and Midterm Outcomes. Journal of Endourology. 34(4). 469–474. 6 indexed citations
12.
Huang, Qingbo, Cheng Peng, Hongzhao Li, et al.. (2019). The experience of robot-assisted thrombectomy in treating renal tumor with Mayo level III to IV inferior vena caval thrombus (report of 5 cases). Zhonghua miniao waike zazhi. 40(2). 81–85.
14.
Huang, Qingbo, Yin Sun, Xin Ma, et al.. (2017). Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma. Nature Communications. 8(1). 918–918. 67 indexed citations
15.
Marder, Wendy, Jason S. Knight, Mariana J. Kaplan, et al.. (2016). Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies. Lupus Science & Medicine. 3(1). e000134–e000134. 78 indexed citations
16.
Gao, Yu, Hongzhao Li, Xin Ma, et al.. (2016). KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1. Cancer Research. 77(2). 330–342. 63 indexed citations
17.
Guo, Gang, et al.. (2015). A New 2-Micrometer Continuous Wave Laser Method for Management of the Distal Ureter in Retroperitoneal Laparoscopic Nephroureterectomy. Journal of Endourology. 29(4). 430–434. 8 indexed citations
18.
Xiao, Huasheng, Qiuhua Huang, Fang‐Xiong Zhang, et al.. (2002). Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proceedings of the National Academy of Sciences. 99(12). 8360–8365. 417 indexed citations
19.
Chen, Zhong, et al.. (2001). Expression of multidrug-associated protein, P-glycoprotein, P53 and Bcl-2 proteins in bladder cancer and clinical implication. Current Medical Science. 21(1). 56–58. 7 indexed citations
20.
Zhang, Xu, et al.. (1970). Transurethral Resection of Bladder Tumor: Novel Techniques in a New Era. PubMed. 10(2). 1–1. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026